Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80975210013

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80975210013 and manufactured by TOCARE INDUSTRIA E COMERCIO DE PRODUTOS MEDICOS S/A. The registration is held by TOCARE INDUSTRIA E COMERCIO DE PRODUTOS MEDICOS S/A with validity until Jul 11, 2032.

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80975210013
Registration Details
ANVISA Registration Number: 80975210013
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

80975210013

25351060627202284

17513528000167

Company Information

Brazil
PT: BRASIL

Dates and Status

Jul 11, 2022

11/07/2032

09/18/2025 19:00:01